Skip to content

Gilead two-drug hep C combination cures 94% of genotype 1 patients in eight weeks

Health systems, not family factors, most crucial in PMTCT outcomes, Kenyan study shows

Widespread support for HIV PrEP among infectious disease doctors in the US and Canada

Starting antiretroviral therapy significantly reduces the risk of decompensated liver disease for men with HIV/HCV co-infection

Study provides information on sexual health of male sex workers in England

HIV treatment in South Africa has had "astounding" benefits

Good adherence to HIV treatment, undetectable viral load, reduce the risk of anal infection with high-risk HPV types for MSM with HIV

Men with penile HPV infection have an increased risk of acquiring HIV

NAM prevention survey results: testing underestimated, support for treatment as prevention, reservations about PrEP